RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q4 2025 · 243 positions · Total reported value $1.82B · Top-10 concentration 24.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 243 equity positions with a combined reported value of $1.82B. The filing implies a diversified portfolio: its ten largest positions account for 24.3% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q4 2025 were LGND ($52.87M), ARLO ($50.04M), FOLD ($49.98M). By sector, the heaviest allocations are Health Care 29.8%, Consumer Discretionary 25.4%. Versus the prior quarter, allocation shifted toward Health Care (+2.9pp), Utilities (+2.7pp) and away from Industrials (-0.7pp), Technology (-1.0pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 92% of names.

The largest new positions opened in Q4 2025 were BIRK ($19.08M), G ($12.09M), IWC ($4.53M).

Of the 12 positions fully exited versus the prior quarter, the largest were WNS ($7.77M), COST ($6.25M), VRNA ($4.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • BIRK BIRKENSTOCK HOLDING PLC · $19.08M
  • G GENPACT LIMITED · $12.09M
  • IWC iShares Russell Micro-Cap ETF · $4.53M
  • IWM ISHARES TR · $4.28M
  • GPOR GULFPORT ENERGY CORP · $4.21M
  • CWAN CLEARWATER ANALYTICS HLDGS I · $1.47M
  • IFF INTERNATIONAL FLAVORS&FRAGRA · $468.36K
  • COLM COLUMBIA SPORTSWEAR CO · $207.80K

Fully Exited (vs previous quarter)

  • WNS WNS HLDGS LTD · prev qtr: $7.77M
  • COST COSTCO WHOLESALE CORPORATION · prev qtr: $6.25M
  • VRNA VERONA PHARMA PLC · prev qtr: $4.88M
  • PRO PROS HOLDINGS INC · prev qtr: $2.04M
  • IAS INTEGRAL AD SCIENCE HLDNG CO · prev qtr: $2.02M
  • SRRK SCHOLAR ROCK HLDG CORP · prev qtr: $1.90M
  • CVGW CALAVO GROWERS INC · prev qtr: $1.79M
  • DCBO DOCEBO INC · prev qtr: $1.75M

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 29.8%
Technology 18.9%
Financials 3.6%
Utilities 2.7%
Other 9.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 279.63K $52.87M 2.91%
2.91%
Reduce
2 3.58M $50.04M 2.75%
2.75%
Add
3 3.51M $49.98M 2.75%
2.75%
Add
4 106.52K $48.49M 2.67%
2.67%
Reduce
5 651.56K $47.49M 2.61%
2.61%
Reduce
6 981.31K $46.92M 2.58%
2.58%
Reduce
7 663.79K $41.80M 2.30%
2.30%
Add
8 765.94K $35.76M 1.97%
1.97%
Add
9 62.51K $35.11M 1.93%
1.93%
Reduce
10 172.97K $33.06M 1.82%
1.82%
Reduce
11 914.24K $32.07M 1.77%
1.77%
Reduce
12 145.05K $30.93M 1.70%
1.70%
Reduce
13 500.60K $30.88M 1.70%
1.70%
Reduce
14 219.18K $29.79M 1.64%
1.64%
Reduce
15 427.78K $27.78M 1.53%
1.53%
Add
16 884.53K $27.53M 1.51%
1.51%
Add
17 1.14M $27.11M 1.49%
1.49%
Add
18 128.57K $26.52M 1.46%
1.46%
Reduce
19 744.23K $26.16M 1.44%
1.44%
Reduce
20 250.08K $25.98M 1.43%
1.43%
Add
21 174.14K $25.94M 1.43%
1.43%
Hold
22 596.43K $24.60M 1.35%
1.35%
Add
23 833.79K $23.81M 1.31%
1.31%
Add
24 467.89K $23.25M 1.28%
1.28%
Reduce
25 528.16K $22.72M 1.25%
1.25%
Add
26 337.50K $19.97M 1.10%
1.10%
Add
27 112.42K $19.74M 1.09%
1.09%
Add
28 651.75K $19.68M 1.08%
1.08%
Reduce
29 466.58K $19.08M 1.05%
1.05%
New
30 230.02K $18.52M 1.02%
1.02%
Reduce
31 214.00K $18.47M 1.02%
1.02%
Add
32 586.01K $17.76M 0.98%
0.98%
Add
33 362.00K $17.74M 0.98%
0.98%
Add
34 388.80K $17.22M 0.95%
0.95%
Reduce
35 223.48K $17.01M 0.94%
0.94%
Reduce
36 603.74K $16.13M 0.89%
0.89%
Reduce
37 667.06K $16.07M 0.89%
0.89%
Add
38 355.91K $15.29M 0.84%
0.84%
Add
39 74.23K $14.90M 0.82%
0.82%
Add
40 1.90M $14.85M 0.82%
0.82%
Add
41 182.28K $14.78M 0.81%
0.81%
Add
42 110.28K $14.65M 0.81%
0.81%
Reduce
43 98.02K $13.90M 0.77%
0.77%
Reduce
44 683.46K $13.05M 0.72%
0.72%
Hold
45 164.45K $12.99M 0.71%
0.71%
Hold
46 1.97M $12.87M 0.71%
0.71%
Add
47 1.08M $12.62M 0.69%
0.69%
Add
48 102.53K $12.44M 0.69%
0.69%
Add
49 258.38K $12.09M 0.67%
0.67%
New
50 254.78K $11.73M 0.65%
0.65%
Reduce

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 243 equity positions worth $1.82B in aggregate; its largest disclosed positions were LGND ($52.87M), ARLO ($50.04M), FOLD ($49.98M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.82B of long equity holdings across 243 positions as of 2025-Q4. Top-10 holdings account for 24.3% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →